Guo-he Q. Lin
Hefei, 230601, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Treatment outcomes of fruquintinib combined with PD-1 inhibitors in advanced colorectal cancer: a reconstructed patient-level meta-analysis of retrospective real-world studies.
Journal: BMC cancer
Published: April 06, 2026
Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis.
Journal: Frontiers in immunology
Published: September 17, 2024
The efficacy and safety of antiangiogenesis tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: A meta-analysis of prospective studies.
Journal: Medicine
Published: August 02, 2024
Clinical management of thrombocytopenia in cirrhosis
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: July 04, 2024
Emerging chemotherapy-based treatments in anaplastic thyroid cancer: an updated analysis of prospective studies.
Journal: Frontiers in endocrinology
Published: February 13, 2024
Lenvatinib Versus Atezolizumab Plus Bevacizumab in the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis of Real-World Studies.
Journal: Targeted oncology
Published: January 16, 2024
Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies.
Journal: Frontiers in endocrinology
Published: November 27, 2023
The efficacy of adebrelimab compared with durvalumab and atezolizumab in untreated extensive-stage small-cell lung cancer: a survival analysis of reconstructed patient-level data.
Journal: Frontiers in immunology
Published: March 13, 2023
A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer.
Journal: Medicine
Published: November 18, 2022
Last Updated: 09/26/2026